Delivery Order SPE2DB20D6037-SPE2DB23FD0QB
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,020.36 firm fixed-price delivery order is for the supply of 4557035328 - DIAZEPAM 50 MG/10 ML VIAL 10ML. This award is part of DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue delivery orders for a comprehensive range of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,159.15 firm fixed-price delivery order is for the supply of 4559072490 - DIAZEPAM 10 MG/2 ML CARPUJECT 2ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,795.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of DIAZEPAM INJECTION, a specialized pharmaceutical product, with a completion date of November 15, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This federal contract award, with the ID SPE2DX15D9628|SPE2DX18FUZF1, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $97,116.90 firm fixed-price delivery order is for the supply of 4539631323 DIAZEPAM 5MG/ML 10S, a pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,518.00 for the supply of DIAZEPAM INJECTION, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of November 18, 2024. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,017.60 firm fixed-price contract is for the supply of a specific pharmaceutical product, DIAZEPAM 50 MG/10 ML VIAL 10ML. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the company's $499,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $87,248.26, is for the delivery of diazepam 5mg/ml 10s, a pharmaceutical product, to support the medical supply needs of military health facilities. As a key supplier in the federal pharmaceutical supply chain, DMS...
- The U.S. Government has awarded a Delivery Order (Contract ID: SPE2DX15D9905|SPE2DX24FQZCZ) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,795.00 firm fixed-price contract is for the delivery of DIAZEPAM INJECTION and has a period of performance ending on May 13, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $95,972.94 firm fixed-price delivery order is for the supply of Diazepam 5mg/ml, a prescription pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $98,136.50, is for the delivery of Diazepam 5mg/ml 10s, a specialized pharmaceutical product. The contract has an ultimate completion date of October 19, 2017. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB23FD0QBDelivery Order
This federal contract award, with ID SPE2DB20D6037|SPE2DB23FD0QB, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,598.91 firm fixed-price delivery order is for the supply of 4561647606 - DIAZEPAM 50 MG/10 ML VIAL 10ML, with an ultimate completion date of August 1, 2023. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This award is part of that larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 7/31/23 |